BiondVax Pharmaceuticals is an Israeli biopharmaceutical company that develops and sells medical products to aid in fighting infectious diseases and other ailments. Their licensing and collaboration agreements for the development of COVID-19 nanosized antibodies and others allow for the commercialization of disease prevention and treatment products. The company was founded in 2003 with headquarters in Jerusalem.